▁London 10.375
- 7.328125
based 5.19140625
▁ph 7.79296875
arma 0.4736328125
ce 0.15673828125
ut 3.4609375
ical 0.07781982421875
▁company 1.8583984375
▁Sky 10.859375
e 5.76953125
Ph 8.9296875
arma 0.08245849609375
▁has 6.609375
▁predicted 10.1015625
▁that 1.5341796875
▁ 4.57421875
1 1.84765625
9 2.951171875
9 2.552734375
8 1.9736328125
▁will 3.556640625
▁be 0.84130859375
▁a 1.4951171875
▁“ 23.375
mag 12.421875
ic 4.29296875
▁year 6.18359375
” 23.53125
▁of 6.48046875
▁growth 9.359375
▁for 3.662109375
▁its 5.75
▁invest 8.8046875
ors 1.02734375
▁and 2.603515625
▁share 5.22265625
hold 0.036468505859375
ers 0.00432586669921875
, 3.29296875
▁thanks 7.96875
▁to 0.419677734375
▁a 2.9375
▁number 6.42578125
▁of 0.60205078125
▁up 7.43359375
coming 1.203125
▁product 7.734375
▁launch 0.72998046875
es 0.10992431640625
▁and 2.41015625
▁partners 5.671875
hips 0.11651611328125
. 1.994140625
<0x0A> 1.087890625
S 3.14453125
ky 0.1805419921875
e 0.484375
Ph 0.442626953125
arma 0.0065765380859375
▁has 1.7216796875
▁a 3.61328125
▁strong 3.982421875
▁track 1.7236328125
▁record 0.045684814453125
▁of 0.455078125
▁developing 2.99609375
▁and 1.6123046875
▁commercial 1.1923828125
izing 1.203125
▁innov 1.9248046875
ative 0.00928497314453125
▁drug 4.1171875
▁delivery 2.423828125
▁techn 1.080078125
ologies 0.000640869140625
, 1.603515625
▁including 1.9892578125
▁in 4.734375
hal 0.87060546875
ation 0.46142578125
▁and 2.1796875
▁or 1.724609375
al 0.0204010009765625
▁form 2.6796875
ulations 0.0347900390625
. 1.609375
▁Its 3.0859375
▁current 4.58984375
▁product 1.841796875
▁port 1.0244140625
folio 0.0024814605712890625
▁includes 0.64501953125
▁treat 5.640625
ments 0.0008025169372558594
▁for 0.0963134765625
▁resp 2.498046875
ir 0.0010881423950195312
atory 2.396106719970703e-05
▁dise 1.3173828125
ases 0.00013768672943115234
, 0.67431640625
▁pain 3.27734375
▁management 1.4892578125
, 0.272705078125
▁and 1.2958984375
▁mig 6.3046875
raine 0.416015625
▁relief 4.80078125
. 0.32421875
<0x0A> 0.9951171875
The 1.9970703125
▁company 0.83447265625
▁has 1.33984375
▁several 4.41015625
▁major 4.8515625
▁product 2.16796875
▁launch 0.3759765625
es 0.0220489501953125
▁scheduled 1.619140625
▁for 0.381103515625
▁ 0.74755859375
1 2.783203125
9 0.022216796875
9 0.002719879150390625
8 0.115478515625
, 0.4892578125
▁including 0.242919921875
▁a 2.1328125
▁new 1.349609375
▁in 1.978515625
hal 0.188720703125
er 1.1328125
▁for 0.5576171875
▁the 1.4287109375
▁treatment 0.1204833984375
▁of 0.00620269775390625
▁chron 2.333984375
ic 0.00036025047302246094
▁ob 0.1119384765625
struct 0.00022673606872558594
ive 0.00019693374633789062
▁pul 0.01910400390625
mon 0.0001823902130126953
ary 0.000476837158203125
▁disease 0.068115234375
▁( 0.6240234375
CO 0.016448974609375
PD 0.0015201568603515625
), 0.89306640625
▁which 2.62890625
▁affect 7.9609375
s 0.002475738525390625
▁millions 2.30078125
▁of 0.07958984375
▁people 0.43212890625
▁world 0.5966796875
wide 0.0079803466796875
. 0.5693359375
▁Sky 2.068359375
e 0.00458526611328125
Ph 0.07281494140625
arma 0.0011396408081054688
’ 27.90625
s 2.775390625
▁new 2.380859375
▁in 0.67138671875
hal 0.027008056640625
er 0.09906005859375
▁uses 4.65625
▁a 1.0771484375
▁unique 2.314453125
▁dry 3.841796875
▁pow 0.287109375
der 0.00037384033203125
▁form 2.96875
ulation 0.029876708984375
▁that 1.85546875
▁is 1.6865234375
▁easier 4.5234375
▁to 0.1944580078125
▁use 1.3193359375
▁and 0.95751953125
▁more 1.48046875
▁convenient 0.9326171875
▁for 1.142578125
▁patients 0.1798095703125
▁than 1.16796875
▁traditional 1.8984375
▁in 1.2470703125
hal 0.08770751953125
ers 0.149658203125
. 0.2626953125
<0x0A> 0.74072265625
In 2.28515625
▁addition 0.44287109375
, 0.258056640625
▁Sky 0.458251953125
e 0.003017425537109375
Ph 0.0113983154296875
arma 0.0122222900390625
▁is 1.349609375
▁entering 5.3046875
▁into 0.61328125
▁several 3.005859375
▁partners 1.947265625
hips 0.1065673828125
▁and 1.3662109375
▁lic 1.5078125
ens 0.0274505615234375
ing 0.001789093017578125
▁agre 0.28369140625
ements 3.254413604736328e-05
▁that 2.86328125
▁will 0.54638671875
▁expand 1.9140625
▁its 0.406005859375
▁product 0.99267578125
▁offer 2.634765625
ings 0.00023984909057617188
▁and 1.291015625
▁market 4.07421875
▁reach 1.068359375
. 0.2332763671875
▁The 1.2509765625
▁company 0.132080078125
▁recently 2.6015625
▁signed 1.2314453125
▁a 0.61767578125
▁deal 3.0546875
▁with 0.184326171875
▁US 6.17578125
- 0.59814453125
based 0.00949859619140625
▁drug 3.5546875
maker 2.515625
▁El 6.6796875
an 0.08209228515625
▁Ph 1.5654296875
arma 0.0027065277099609375
ce 0.021484375
ut 0.000621795654296875
ical 0.00209808349609375
s 0.427978515625
▁to 0.89892578125
▁develop 1.0673828125
▁novel 5.77734375
▁drug 1.99609375
▁delivery 0.306640625
▁techn 0.5947265625
ologies 0.00041675567626953125
▁for 0.8486328125
▁the 1.1513671875
▁treatment 0.2127685546875
▁of 0.00733184814453125
▁ne 3.560546875
uro 0.05950927734375
log 0.302001953125
ical 0.00641632080078125
▁dis 0.6923828125
orders 0.0008807182312011719
. 0.64013671875
▁It 4.90234375
▁also 0.6669921875
▁announced 2.513671875
▁a 0.69287109375
▁lic 1.841796875
ens 0.0031642913818359375
ing 0.00024628639221191406
▁agreement 0.305908203125
▁with 0.075927734375
▁Italy 5.98046875
’ 25.859375
s 2.58203125
▁Ch 6.6796875
ies 0.52783203125
i 0.134033203125
▁Far 0.179443359375
ma 0.00021219253540039062
ce 0.0036182403564453125
ut 0.0889892578125
ici 0.288330078125
▁for 2.287109375
▁the 0.49755859375
▁distribution 5.16796875
▁and 1.4951171875
▁market 0.904296875
ing 0.0019330978393554688
▁of 0.1905517578125
▁a 2.767578125
▁range 4.1796875
▁of 0.0026531219482421875
▁resp 5.078125
ir 0.00308990478515625
atory 0.0011692047119140625
▁products 1.4140625
▁in 0.74560546875
▁Europe 1.595703125
. 0.326171875
<0x0A> 0.433837890625
“ 24.5
We 11.3125
’ 23.421875
re 4.37109375
▁very 2.5234375
▁optim 2.6015625
istic 0.00858306884765625
▁about 0.20458984375
▁our 1.7626953125
▁prospect 1.2236328125
s 0.008636474609375
▁for 0.77294921875
▁ 0.572265625
1 0.0112457275390625
9 0.0007987022399902344
9 0.000858306884765625
8 0.0312042236328125
▁and 1.73046875
▁beyond 1.2451171875
,” 24.265625
▁said 9.3046875
▁Sky 1.517578125
e 0.009490966796875
Ph 0.01708984375
arma 0.04290771484375
▁CE 0.6943359375
O 0.006969451904296875
▁Jer 5.82421875
emy 0.5595703125
▁Sc 7.1953125
ud 3.626953125
am 0.0946044921875
ore 0.007747650146484375
. 0.304931640625
▁“ 25.53125
We 3.28515625
▁have 1.6943359375
▁a 0.7333984375
▁number 2.4453125
▁of 0.01097869873046875
▁exc 1.685546875
iting 0.00033164024353027344
▁new 1.3955078125
▁products 1.1640625
▁in 0.7060546875
▁development 0.7587890625
, 1.111328125
▁as 2.77734375
▁well 0.0121307373046875
▁as 0.01407623291015625
▁strong 2.728515625
▁partners 1.9404296875
hips 0.04736328125
▁in 2.767578125
▁place 0.1798095703125
▁that 0.98095703125
▁will 0.38232421875
▁help 1.576171875
▁us 0.97265625
▁achieve 2.365234375
▁our 0.2366943359375
▁growth 2.099609375
▁targets 2.337890625
.” 24.0
<0x0A> 3.5
In 3.166015625
vest 2.904296875
ors 0.474853515625
▁seem 6.62109375
▁b 3.87890625
ull 0.0008597373962402344
ish 0.00031828880310058594
▁on 1.0380859375
▁Sky 0.34033203125
e 0.018646240234375
Ph 0.02642822265625
arma 0.024169921875
’ 23.515625
s 2.259765625
▁prospect 0.48583984375
s 0.004604339599609375
▁as 2.6484375
▁well 0.1138916015625
▁– 8.578125
▁the 1.1513671875
▁company 1.2529296875
’ 24.671875
s 0.62744140625
▁stock 1.251953125
▁price 1.6787109375
▁has 0.70751953125
▁ris 1.2841796875
en 0.0025424957275390625
▁stead 3.734375
ily 0.0005393028259277344
▁over 1.603515625
▁the 0.0300445556640625
▁past 0.2440185546875
▁year 1.2861328125
, 0.75390625
▁and 1.767578125
▁anal 3.4921875
yst 0.00024819374084472656
s 0.047515869140625
▁are 1.41796875
▁predict 2.896484375
ing 0.0025272369384765625
▁continued 3.544921875
▁growth 0.7412109375
▁in 0.73828125
▁ 0.48681640625
1 0.006938934326171875
9 0.00021147727966308594
9 0.00020623207092285156
8 0.0247955322265625
. 0.57373046875
<0x0A> 1.515625
“ 23.265625
S 2.787109375
ky 0.0310211181640625
e 0.0279998779296875
Ph 0.024261474609375
arma 0.0496826171875
▁has 1.6318359375
▁a 0.87890625
▁strong 1.5791015625
▁pipeline 3.724609375
▁of 0.23681640625
▁innov 2.40625
ative 0.0204315185546875
▁products 1.3681640625
▁and 1.66015625
▁a 2.572265625
▁proven 2.234375
▁track 0.1405029296875
▁record 0.01279449462890625
▁of 0.11285400390625
▁commercial 2.4140625
▁success 1.6728515625
,” 23.078125
▁said 1.255859375
▁ph 9.4375
arma 0.0670166015625
ce 0.11236572265625
ut 0.0023975372314453125
ical 0.0024433135986328125
s 4.11328125
▁anal 0.6884765625
yst 0.00036597251892089844
▁Caroline 8.1328125
▁Davis 6.02734375
. 0.9814453125
▁“ 21.546875
There 4.328125
’ 23.734375
s 1.572265625
▁a 1.2392578125
▁lot 0.76708984375
▁of 0.284912109375
▁excitement 2.185546875
▁and 3.015625
▁anticip 3.671875
ation 0.000926971435546875
▁among 3.48046875
▁invest 0.650390625
ors 0.00414276123046875
▁about 1.6748046875
▁what 2.806640625
▁they 4.59765625
▁will 4.90234375
▁achieve 4.39453125
▁in 0.65771484375
▁the 2.4765625
▁coming 1.3056640625
▁year 0.484619140625
.” 22.265625
<0x0A> 0.18701171875
For 3.94921875
▁its 4.296875
▁part 0.07684326171875
, 0.026031494140625
▁Sky 0.1082763671875
e 0.0033588409423828125
Ph 0.005970001220703125
arma 0.003993988037109375
▁is 1.2509765625
▁focused 3.431640625
▁on 0.022796630859375
▁continu 4.90625
ing 0.0059967041015625
▁to 0.2313232421875
▁develop 1.6572265625
▁techn 6.3515625
ologies 0.08526611328125
▁that 0.58349609375
▁improve 2.33984375
▁the 1.0458984375
▁delivery 1.38671875
▁and 2.009765625
▁effic 1.8388671875
acy 0.0009331703186035156
▁of 0.007709503173828125
▁medic 2.263671875
ations 0.70751953125
▁for 3.029296875
▁a 2.306640625
▁wide 1.7890625
▁range 0.1973876953125
▁of 0.003314971923828125
▁th 2.8125
era 0.0005540847778320312
pe 9.775161743164062e-05
ut 0.00127410888671875
ic 0.00463104248046875
▁areas 0.5302734375
. 0.396240234375
<0x0A> 1.5185546875
“ 22.5625
We 1.24609375
’ 23.90625
re 0.7919921875
▁committed 3.173828125
▁to 0.00540924072265625
▁stay 5.63671875
ing 0.005947113037109375
▁on 1.56640625
▁the 0.1744384765625
▁cutting 0.52294921875
▁edge 0.098876953125
▁of 0.1378173828125
▁drug 1.6318359375
▁delivery 0.262451171875
,” 24.53125
▁said 0.305419921875
▁Sc 0.7861328125
ud 0.0025959014892578125
am 0.005214691162109375
ore 0.0109710693359375
. 0.07049560546875
▁“ 21.171875
O 2.966796875
ur 0.0018205642700195312
▁goal 2.119140625
▁is 0.102783203125
▁to 0.034820556640625
▁provide 2.490234375
▁patients 1.7578125
▁with 0.1964111328125
▁better 2.6015625
, 2.466796875
▁more 0.60107421875
▁effective 1.294921875
▁treat 1.162109375
ments 0.00039958953857421875
▁that 1.86328125
▁improve 2.232421875
▁their 0.60107421875
▁quality 0.4189453125
▁of 0.00975799560546875
▁life 0.00907135009765625
.” 22.5625
<0x0A> 0.11419677734375
With 5.1171875
▁a 1.6083984375
▁prom 3.923828125
ising 0.0010080337524414062
▁pipeline 0.1693115234375
▁of 0.423583984375
▁products 1.7392578125
▁and 0.80517578125
▁strong 2.068359375
▁partners 1.255859375
hips 0.0189361572265625
▁in 0.364013671875
▁place 0.0136871337890625
, 0.08966064453125
▁Sky 0.08441162109375
e 0.001678466796875
Ph 0.005218505859375
arma 0.005893707275390625
▁seems 2.275390625
▁well 0.82421875
- 0.650390625
position 0.06402587890625
ed 0.001972198486328125
▁to 0.51806640625
▁deliver 2.85546875
▁on 0.9814453125
▁its 0.05615234375
▁promise 2.662109375
▁of 0.677734375
▁a 4.62109375
▁“ 25.0625
mag 7.51953125
ic 0.214111328125
▁year 0.192138671875
” 23.734375
▁of 4.640625
▁growth 0.2020263671875
▁for 0.86962890625
▁invest 1.771484375
ors 0.002269744873046875
▁in 1.6748046875
▁ 0.16796875
1 0.005611419677734375
9 0.0001232624053955078
9 0.0002224445343017578
8 0.00390625
. 0.415771484375
